KEY FEATURES
| Full Name | Heparin Binding Epidermal Growth Factor Like Growth Factor |
|---|---|
| Synonym | HB-EGF; DTR; DTS; DTSF; HEGFL; Diphtheria Toxin Receptor; Proheparin-binding EGF-like growth factor; Diphtheria toxin receptor |
| Assay Type | Sandwich |
| Reactivity | Rat |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6.1pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Rat HBEGF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Rat HBEGF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Rat HBEGF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Rat HBEGF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Rat HBEGF. You can calculate the concentration of Rat HBEGF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Rat HBEGF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 46.07 | 131.37 | 341.64 | 46.32 | 124.28 | 357.57 |
| Standard deviation | 2.56 | 7.57 | 14.96 | 3.05 | 5.52 | 19.45 |
| CV(%) | 5.55 | 5.76 | 4.38 | 6.59 | 4.44 | 5.44 |
RECOVERY
The recovery of Rat HBEGF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 96-108 | 102 |
| EDTA plasma (n=8) | 90-100 | 95 |
| Cell culture media (n=8) | 89-105 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Rat HBEGF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with HBEGF ELISA Kits
| Egfr ELISA Kit | publications with HBEGF and Egfr |
| Erbb4 ELISA Kit | publications with HBEGF and Erbb4 |
| Adam17 ELISA Kit | publications with HBEGF and Adam17 |
| Erbb3 ELISA Kit | publications with HBEGF and Erbb3 |
| Nrg1 ELISA Kit | publications with HBEGF and Nrg1 |
| Nrg2 ELISA Kit | publications with HBEGF and Nrg2 |
| Grb2 ELISA Kit | publications with HBEGF and Grb2 |
Pathways associated with HBEGF ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Constitutive PI3K/AKT Signaling In Cancer Pathway | Constitutive PI3K/AKT Signaling In Cancer Pathway |
| DAP12 Interactions Pathway | DAP12 Interactions Pathway |
| DAP12 Signaling Pathway | DAP12 Signaling Pathway |
| Disease Pathway | Disease Pathway |
| Downstream Signal Transduction Pathway | Downstream Signal Transduction Pathway |
| Downstream Signaling Events Of B Cell Receptor (BCR) Pathway | Downstream Signaling Events Of B Cell Receptor (BCR) Pathway |
| Downstream Signaling Of Activated FGFR Pathway | Downstream Signaling Of Activated FGFR Pathway |
| EGFR Transactivation By Gastrin Pathway | EGFR Transactivation By Gastrin Pathway |
| ErbB Signaling Pathway | ErbB Signaling Pathway |
Diseases associated with HBEGF ELISA Kit
| Cardiovascular Diseases | publications with HBEGF and Cardiovascular Diseases |
| Disease Models, Animal | publications with HBEGF and Disease Models, Animal |
| Necrosis | publications with HBEGF and Necrosis |
| Inflammation | publications with HBEGF and Inflammation |
| Lung Diseases | publications with HBEGF and Lung Diseases |
| Heart Diseases | publications with HBEGF and Heart Diseases |
| Hyperplasia | publications with HBEGF and Hyperplasia |
| Reperfusion Injury | publications with HBEGF and Reperfusion Injury |
| Liver Diseases | publications with HBEGF and Liver Diseases |
| Hypertrophy | publications with HBEGF and Hypertrophy |
Organs/Tissues associated with HBEGF ELISA Kit
| Muscle | publications with HBEGF and Muscle |
| Skin | publications with HBEGF and Skin |
| Brain | publications with HBEGF and Brain |
| Lung | publications with HBEGF and Lung |
| Intestine | publications with HBEGF and Intestine |
| Heart | publications with HBEGF and Heart |
| Embryonic Tissue | publications with HBEGF and Embryonic Tissue |
| Bone | publications with HBEGF and Bone |
| Eye | publications with HBEGF and Eye |
| Prostate | publications with HBEGF and Prostate |